These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24838211)

  • 1. Ready or not: personalized medicine is coming. IEEE Pulse talks with Michael Snyder about its potential.
    Snyder M; Mertz L
    IEEE Pulse; 2014; 5(3):45-7. PubMed ID: 24838211
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathology in the era of personlized medicine].
    Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2008 Apr; 37(4):217-8. PubMed ID: 18844027
    [No Abstract]   [Full Text] [Related]  

  • 3. Precision medicine initiative.
    Porche DJ
    Am J Mens Health; 2015 May; 9(3):177. PubMed ID: 25759367
    [No Abstract]   [Full Text] [Related]  

  • 4. [Personalized medicine - the wheel has been reinvented].
    Kraft K
    Forsch Komplementmed; 2014; 21(3):152-3. PubMed ID: 25060153
    [No Abstract]   [Full Text] [Related]  

  • 5. The computable cell: A step toward personalized medicine.
    Gough NR
    Sci Signal; 2015 Dec; 8(408):eg6. PubMed ID: 26696628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction: Personalized medicine: what is it and what are the challenges?
    Sigman M
    Fertil Steril; 2018 Jun; 109(6):944-945. PubMed ID: 29935651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joseph C. Wu: Envisioning Personalized Medicine and Clinical Trials in a Dish.
    Ince S; Wu JC
    Circ Res; 2015 Sep; 117(7):599-602. PubMed ID: 26358110
    [No Abstract]   [Full Text] [Related]  

  • 8. Personalized medicine in cancer: where are we today?
    Turnbull AK
    Future Oncol; 2015; 11(20):2795-8. PubMed ID: 26344657
    [No Abstract]   [Full Text] [Related]  

  • 9. Personalized medicine in lymphoma: is it worthwhile? The mantle cell lymphoma experience.
    Dreyling M; Ferrero S;
    Haematologica; 2015 Jun; 100(6):706-8. PubMed ID: 26034112
    [No Abstract]   [Full Text] [Related]  

  • 10. Developing the Scientific Infrastructure to Produce Ethnogenetically-Specific Personalized Medicine.
    Ehrlich GD
    Genet Test Mol Biomarkers; 2015 Sep; 19(9):465-6. PubMed ID: 26308678
    [No Abstract]   [Full Text] [Related]  

  • 11. Myeloproliferative neoplasms and personalized medicine: the perfect match?
    Kiladjian JJ; Harrison C
    Haematologica; 2015 Dec; 100(12):1493-4. PubMed ID: 26628630
    [No Abstract]   [Full Text] [Related]  

  • 12. Personalized medicine: CCO's vision, accomplishments and future plans.
    Guo J; Kamel-Reid S; Rutherford M; Hart J; Melamed S; Pollett A
    Healthc Q; 2015; 17 Spec No():41-3. PubMed ID: 25562133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward individualized treatment in urologic oncology.
    Rini BI
    Urol Oncol; 2015 Apr; 33(4):170. PubMed ID: 25661236
    [No Abstract]   [Full Text] [Related]  

  • 14. Making precision surgical strategies a reality: are we ready for a paradigm shift in thoracic surgical oncology?
    Migliore M; Halezeroglu S; Mueller MR
    Future Oncol; 2020 Jun; 16(16s):1-5. PubMed ID: 32447984
    [No Abstract]   [Full Text] [Related]  

  • 15. Can precision medicine reduce overdiagnosis?
    Hunt S; Jha S
    Acad Radiol; 2015 Aug; 22(8):1040-1. PubMed ID: 26100198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is precision medicine ready for use in breast cancer?
    Pusztai L
    Clin Adv Hematol Oncol; 2016 Dec; 14(12):964-966. PubMed ID: 28212357
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacogenomics in pediatrics: personalized medicine showing eminent promise.
    Mele C; Goldschmidt K
    J Pediatr Nurs; 2014; 29(4):378-82. PubMed ID: 24880100
    [No Abstract]   [Full Text] [Related]  

  • 18. From standard treatment to personalized medicine: role of IDH1 mutations in low-grade glioma evolution and treatment.
    Ferroli P; Acerbi F; Finocchiaro G
    World Neurosurg; 2010 Apr; 73(4):234-6. PubMed ID: 20849763
    [No Abstract]   [Full Text] [Related]  

  • 19. The limitations of evidence-based medicine compel the practice of personalized medicine.
    Einav S; O'Connor M
    Intensive Care Med; 2024 Aug; 50(8):1323-1326. PubMed ID: 38935271
    [No Abstract]   [Full Text] [Related]  

  • 20. The evolution of computational hemodynamics as a clinical tool in decision making, patient specific treatment and clinical management. Part II.
    Gallo D; Anayiotos A; Morbiducci U
    Ann Biomed Eng; 2015 Jun; 43(6):1273-4. PubMed ID: 25986956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.